News

June 23, 2017June 23, 2017

Virginia Pascual Receives Lupus Insight Prize for Work on Events That Lead to Flare-ups

News

New York researcher Virginia Pascual has received the $150,000 Lupus Insight Prize for work that promises to improve our understanding of events leading to the disease’s flare-ups. Pascual is a pioneer ... Read more

June 22, 2017June 22, 2017

Cause of Neuropsychiatric Ills Common to Lupus Seen in Study, Potential Treatment Raised

News

Neuropsychiatric symptoms in people with systemic lupus erythematosus may be caused by increased levels of the inflammatory molecule interferon-alpha in their brains, according to a study published in the journal Nature. ... Read more

June 21, 2017June 21, 2017

Voclosporin Combo Does Better Than Standard Therapy in Eliminating Lupus Nephritis, Trial Shows

News

A combination of voclosporin and standard therapy eliminated the inflamed-kidney condition lupus nephritis in twice as many patients as those who received standard care alone, according to a Phase ... Read more

June 20, 2017June 20, 2017

Celgene’s CC-220 Seen to Benefit Lupus Patients, But Researchers Urge Caution

News

A Phase 2a trial (NCT02185040) evaluating Celgene International‘s CC-220 in systemic lupus erythematosus (SLE) reports promising results, according to data presented at the Annual European Congress of Rheumatology (EULAR) 2017, held June ... Read more

June 19, 2017June 19, 2017

Benlysta Achieves Sustained Disease Control in Lupus, Concludes GSK’s 10-year Study

News

Patients with active systemic lupus erythematosus (SLE) were able to control their disease with Benlysta (belimumab) plus standard of care (prednisone), pharmaceutical giant GSK said in announcing the results from a 10-year continuation ... Read more

June 16, 2017June 16, 2017

Lupus Awareness Campaign Aims to Let African-American and Hispanic Women Know They Are at Higher Risk

News

The Lupus Foundation of America and American College of Rheumatology have started a campaign to let African-American and Hispanic women know that they are at higher risk of developing lupus. The aim of ... Read more

June 15, 2017June 15, 2017

MyHealthTeams, Which Created a Lupus Social Network, Obtains Additional Financing

News

MyHealthTeams, a San Francisco-based start-up that creates social networks for people with lupus and other chronic diseases, has obtained a second multi-million-dollar round of financing from Qiming Venture Funds. The ... Read more

June 14, 2017June 14, 2017

Exagen Diagnostics Develops Blood Test to Monitor Lupus and Lupus Nephritis

News

Exagen Diagnostics has developed a blood test to keep tabs on the conditions of people with lupus and the kidney disease lupus nephritis. The company has made the test, which it ... Read more

June 13, 2017June 13, 2017

No Unusual Pregnancy Risk Seen for Lupus Patients in Remission from Kidney Disease, Study Says

News

Lupus patients with a history of kidney disease, but now in remission, should not be advised against a wanted pregnancy — even if they show serologic activity, or positive ... Read more

June 12, 2017June 12, 2017

Injected Benlysta Is Effective Alternative to IV for Treating Lupus, Phase 3 Trial Shows

News

An injected formulation of Benlysta (belimumab) is a safe and effective lupus treatment, according to a Phase 3 clinical trial that tested an alternative to administering the therapy intravenously. Researchers ... Read more